Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
Nathan Collins talks about how the SynFini automated chemistry platform is accelerating drug development and discovery.
Read more from SRI
-
SRI research aims to make generative AI more trustworthy
Researchers have developed a new framework that reduces generative AI hallucinations by up to 32%.
-
Transforming matter: Researchers create perfect crystals from amorphous blobs
SRI aims to create a new electronic device class made of two or more semiconductors.
-
2024 at SRI: A year of breakthroughs
Delivering world-changing solutions for a safer, healthier, and more sustainable future.